Literature DB >> 5394457

[Physico-chemical and analytical studies on HB 419].

P Hajdú, K F Kohler, F H Schmidt, H Spingler.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5394457

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  7 in total

1.  Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.

Authors:  P J Bijlstra; J A Lutterman; F G Russel; T Thien; P Smits
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

2.  Extrapancreatic and pancreatic actions of glibenclamide in rats.

Authors:  W Heptner; A Zermatten; H M Kellner; O Christ; J P Felber
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

3.  Absorption of glibenclamide from different sites of the gastro-intestinal tract.

Authors:  D Brockmeier; H G Grigoleit; H Leonhardt
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

5.  A radioimmunoassay for determination of glibenclamide and other sulfonylureas.

Authors:  W Heptner; M Badian; S Baudner; C Hellstern; R Irmisch; W Rupp; K Weimer; H Wissmann
Journal:  Pharm Res       Date:  1984-09       Impact factor: 4.200

Review 6.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

7.  Experiment stands corrected: accurate prediction of the aqueous pK a values of sulfonamide drugs using equilibrium bond lengths.

Authors:  Beth A Caine; Maddalena Bronzato; Paul L A Popelier
Journal:  Chem Sci       Date:  2019-05-29       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.